See more : 4D pharma plc (DDDD.L) Income Statement Analysis – Financial Results
Complete financial analysis of PT Berkah Beton Sadaya Tbk (BEBS.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Berkah Beton Sadaya Tbk, a leading company in the Construction Materials industry within the Basic Materials sector.
- OC Oerlikon Corporation AG (OERL.SW) Income Statement Analysis – Financial Results
- Ventoux CCM Acquisition Corp. (VTAQU) Income Statement Analysis – Financial Results
- Hifood Group Holdings Co., Limited (0442.HK) Income Statement Analysis – Financial Results
- Jinyu Bio-technology Co., Ltd. (600201.SS) Income Statement Analysis – Financial Results
- American Community Newspapers Inc. (ACNI) Income Statement Analysis – Financial Results
PT Berkah Beton Sadaya Tbk (BEBS.JK)
About PT Berkah Beton Sadaya Tbk
PT Berkah Beton Sadaya Tbk, an industrial supporting infrastructure company, produces and sells ready-mix and precast concrete products in Indonesia. The company was founded in 2019 and is based in Subang, Indonesia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 401.91B | 647.96B | 459.40B | 110.70B | 14.76B |
Cost of Revenue | 328.06B | 474.37B | 308.61B | 76.22B | 12.03B |
Gross Profit | 73.85B | 173.59B | 150.79B | 34.47B | 2.73B |
Gross Profit Ratio | 18.37% | 26.79% | 32.82% | 31.14% | 18.49% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.26B | 4.28B | 2.66B | 2.30B | 1.28B |
Selling & Marketing | 100.24M | 418.97M | 692.34M | 538.97M | -118.00M |
SG&A | 14.20B | 4.70B | 3.35B | 2.84B | 1.16B |
Other Expenses | -254.38M | 10.88B | 5.22B | 3.08B | 0.00 |
Operating Expenses | 14.20B | 15.58B | 8.57B | 5.91B | 1.16B |
Cost & Expenses | 343.02B | 489.96B | 317.17B | 82.14B | 13.20B |
Interest Income | 4.68M | 246.37M | 9.13M | 877.79K | 2.94M |
Interest Expense | 11.72M | 131.41M | 1.10B | 2.08B | 1.26B |
Depreciation & Amortization | 15.77B | 9.91B | 3.63B | 3.60B | 1.42B |
EBITDA | 71.46B | 167.87B | 145.87B | 32.16B | 2.99B |
EBITDA Ratio | 17.78% | 24.41% | 30.98% | 25.86% | 20.25% |
Operating Income | 58.89B | 157.92B | 142.23B | 28.55B | 1.57B |
Operating Income Ratio | 14.65% | 24.37% | 30.96% | 25.79% | 10.61% |
Total Other Income/Expenses | -3.22B | -216.27M | -1.10B | -2.10B | -1.26B |
Income Before Tax | 55.67B | 157.79B | 141.12B | 26.46B | 308.66M |
Income Before Tax Ratio | 13.85% | 24.35% | 30.72% | 23.91% | 2.09% |
Income Tax Expense | 11.85B | 34.87B | 31.05B | 5.67B | 87.42M |
Net Income | 43.81B | 122.92B | 110.08B | 20.79B | 221.24M |
Net Income Ratio | 10.90% | 18.97% | 23.96% | 18.78% | 1.50% |
EPS | 0.97 | 2.73 | 2.84 | 0.38 | 0.00 |
EPS Diluted | 0.97 | 2.73 | 2.84 | 0.38 | 0.00 |
Weighted Avg Shares Out | 45.00B | 45.00B | 38.70B | 55.00B | 55.00B |
Weighted Avg Shares Out (Dil) | 45.00B | 45.00B | 38.70B | 55.00B | 55.00B |
Source: https://incomestatements.info
Category: Stock Reports